These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18446462)

  • 1. Optimization studies on design and evaluation of orodispersible pediatric formulation of indomethacin.
    Singh J; Philip AK; Pathak K
    AAPS PharmSciTech; 2008; 9(1):60-6. PubMed ID: 18446462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified polysaccharides as fast disintegrating excipients for orodispersible tablets of roxithromycin.
    Sharma V; Philip AK; Pathak K
    AAPS PharmSciTech; 2008; 9(1):87-94. PubMed ID: 18446466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and optimization of orodispersible tablets of diazepam.
    Abed KK; Hussein AA; Ghareeb MM; Abdulrasool AA
    AAPS PharmSciTech; 2010 Mar; 11(1):356-61. PubMed ID: 20232267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet.
    Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G
    Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation Design and Optimization of Orodispersible Tablets of Quetiapine Fumarate by Sublimation Method.
    Kalyankar P; Panzade P; Lahoti S
    Indian J Pharm Sci; 2015; 77(3):267-73. PubMed ID: 26180271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of two novel co-processed excipients for direct compression of orodispersible tablets and mini-tablets.
    Kokott M; Lura A; Breitkreutz J; Wiedey R
    Eur J Pharm Biopharm; 2021 Nov; 168():122-130. PubMed ID: 34474110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets.
    Mahesparan VA; Bin Abd Razak FS; Ming LC; Uddin AH; Sarker MZI; Bin LK
    Int J Pharm Compd; 2020; 24(2):148-155. PubMed ID: 32196477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation, Optimization and
    Ejeta F; Gabriel T; Joseph NM; Belete A
    Curr Drug Deliv; 2022; 19(1):129-141. PubMed ID: 34126894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
    Tafere C; Yilma Z; Abrha S; Yehualaw A
    PLoS One; 2021; 16(3):e0246648. PubMed ID: 33725014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing disintegration effectiveness: A thorough evaluation using the SeDeM-ODT expert system for doxylamine succinate orodispersible formulation.
    Ahmad SA; Hasan SMF; Bafail D; Shah SF; Imran M; Sahar T; Ishaqui AA
    PLoS One; 2024; 19(9):e0310334. PubMed ID: 39288134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and Optimization of Fast-Disintegrating Tablet Containing Naratriptan Hydrochloride Using D-Optimal Mixture Design.
    Omar SM; AbdAlla FI; Abdelgawad NM
    AAPS PharmSciTech; 2018 Aug; 19(6):2472-2487. PubMed ID: 29869307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of screw configuration and polymeric carriers on hot-melt extruded taste-masked formulations incorporated into orally disintegrating tablets.
    Morott JT; Pimparade M; Park JB; Worley CP; Majumdar S; Lian Z; Pinto E; Bi Y; Durig T; Repka MA
    J Pharm Sci; 2015 Jan; 104(1):124-34. PubMed ID: 25410968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone.
    Alqurshi A; Kumar Z; McDonald R; Strang J; Buanz A; Ahmed S; Allen E; Cameron P; Rickard JA; Sandhu V; Holt C; Stansfield R; Taylor D; Forbes B; Royall PG
    Mol Pharm; 2016 May; 13(5):1688-98. PubMed ID: 26977787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locust bean gum as superdisintegrant--formulation and evaluation of nimesulide orodispersible tablets.
    Malik K; Arora G; Singh I
    Polim Med; 2011; 41(1):17-28. PubMed ID: 21739929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orodispersible tablets containing taste-masked solid lipid pellets with metformin hydrochloride: Influence of process parameters on tablet properties.
    Petrovick GF; Kleinebudde P; Breitkreutz J
    Eur J Pharm Biopharm; 2018 Jan; 122():137-145. PubMed ID: 29106946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A methodological evaluation and predictive in silico investigation into the multi-functionality of arginine in directly compressed tablets.
    ElShaer A; Kaialy W; Akhtar N; Iyire A; Hussain T; Alany R; Mohammed AR
    Eur J Pharm Biopharm; 2015 Oct; 96():272-81. PubMed ID: 26255158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations.
    Guhmann M; Preis M; Gerber F; Pöllinger N; Breitkreutz J; Weitschies W
    Drug Dev Ind Pharm; 2015 Apr; 41(4):540-51. PubMed ID: 24495274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of taste-masked levocetirizine dihydrochloride orally disintegrating tablets.
    Devireddy SR; Gonugunta CS; Veerareddy PR
    PDA J Pharm Sci Technol; 2009; 63(6):521-6. PubMed ID: 20169858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of different approaches for preparation of chlorzoxazone orodispersible tablets.
    Moqbel HA; ElMeshad AN; El-Nabarawi MA
    Drug Dev Ind Pharm; 2017 May; 43(5):742-750. PubMed ID: 27534668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.